FiercePharmaOriginal article
{"a":[{"_":"CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum","$":{"href":"/pharma/cdmo-argonaut-sheds-life-sciences-diagnostics-division-undisclosed-sum","hreflang":"en"}}]}
Neutral
AI Analysis
Summary
Argonaut Manufacturing Services has divested its life sciences and diagnostics division to private equity firm 1315 Capital for an undisclosed price. The CDMO specializes in aseptic fill-finish services for injectable biologics.
Importance:3/10
Sentiment:
0.00
CDMOdivestitureaseptic fill-finishbiologicsprivate equity
Related Companies
Read the original article
Published by FiercePharma on September 11, 2026 8:16 AM
